(19)
(11) EP 1 407 043 A2

(12)

(88) Date of publication A3:
29.01.2004

(43) Date of publication:
14.04.2004 Bulletin 2004/16

(21) Application number: 02745414.9

(22) Date of filing: 27.06.2002
(51) International Patent Classification (IPC)7C12Q 1/37, A61P 25/00
(86) International application number:
PCT/EP2002/007095
(87) International publication number:
WO 2003/008635 (30.01.2003 Gazette 2003/05)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 04.07.2001 DE 10131899

(71) Applicant: BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG
55216 Ingelheim am Rhein (DE)

(72) Inventors:
  • DORNER-CIOSSEK, Cornelia
    88213 Ravensburg (DE)
  • FUCHS, Klaus
    88433 Schemmerhofen (DE)
  • HAASS, Christian
    82057 Icking (DE)
  • KOSTKA, Markus
    88400 Biberach (DE)
  • STEINER, Harald
    80339 München (DE)

(74) Representative: Mahlbacher, Volker 
Boehringer Ingelheim GmbH,CD Patents
55216 Ingelheim
55216 Ingelheim (DE)

   


(54) GAMMA-SECRETASE IN VITRO SCREENING ASSAY